EQS-News: Proteros biostructures GmbH: Proteros and Adrestia

EQS-News: Proteros biostructures GmbH / Key word(s): Alliance Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases 25.10.2022

Related Keywords

Germany , Martinsried , Bayern , Japan , Villigen , Switzerland General , Switzerland , United Kingdom , Nahren , Nordrhein Westfalen , Tom Donovan , Tom Heightman , Kostenloser Wertpapierhandel , Steve Jackson , Robert Johnson , Shaun Brown , Debora Konz Makino , Development Officer , Mc Services , Vp Business Unit Discovery Solutions , Max Planck Institute Of Biochemistry , Protero Vp Business Unit Discovery Solutions , Dr Sarah Tabrizi At University College London , Distribution Services , Adrestia Therapeutics , Swiss Light Source , Diamond Light Source , Chief Research , Nobel Prize , Max Planck Institute , Lead Optimisation , University College , Professor Steve Jackson , Ahren Innovation Capital , Corporate News , Regulatory Announcements , News , Proteros , Biostructures , Mbh , Adrestia , Nitiate , Ulti , Target , Partnership , Discover , First , Glass , Drugs , Intractable , Enetic , Diseases ,